Your AI-Trained Oncology Knowledge Connection!

Treatment Trends in Adult and Pediatric Acute Lymphoblastic Leukemia

home / publications / supplements / treatment-trends-in-adult-and-pediatric-acute-lymphoblastic-leukemia

Emerging Data Continue to Shape the Role of Blinatumomab in Acute Lymphoblastic Leukemia

February 6th 2025

Adam Duvall, MD, MPH, spotlights new research further elucidating the role of blinatumomab in the acute lymphoblastic leukemia treatment paradigm.

Dr Duvall on Unanswered Questions Regarding the Optimal Role for Blinatumomab in B-ALL

Adam DuVall, MD, MPH

January 30th 2025

Video

Adam DuVall, MD, MPH, discusses remaining questions regarding the optimal use of blinatumomab in frontline B-ALL.

Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD

Ryan Cassaday, MD

January 23rd 2025

Podcast

Ryan Cassaday, MD, discussed insights from trials investigating blinatumomab in patients with B-ALL that were reported at the 2024 ASH Annual Meeting.

Latest Conference Coverage

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512